Aarti Drugs Limited has intimated the stock exchanges about an upcoming Board of Directors meeting scheduled for Thursday, August 27, 2026. The primary agenda of the meeting is to consider and approve the 'Aarti Drugs Limited – Performance Stock Option Plan 2026', along with matters related and incidental thereto.
Pursuant to the SEBI (Prohibition of Insider Trading) Regulations, 2015 and the Company's Code of Conduct for Prevention of Insider Trading, the Trading Window of the Company shall remain closed from August 25, 2026, till August 29, 2026 (both days inclusive).
This disclosure is made in compliance with Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The information is also available on the company's website at www.aartidrugs.com.